Clinical Trials in North Carolina

Showing 7641-7660 of 20,428 trials

DeepView SnapShot Portable (DV-SSP): Device Training Study

NCT05023135

The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.

BurnsWound Heal

SpectralMD251 participantsStarted Sep 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Bridgeport, Connecticut, United States +8 more locations

RECRUITING57 miles

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

NCT05002543

MANTRA is a prospective, multiple-arm, multi-center, global, post-market clinical follow-up study. The main objective is to monitor ongoing safety and performance of the CORCYM devices and accessories used for aortic, mitral and tricuspid valvular diseases in a real-world setting. Corcym S.r.l., is a medical device manufacturer with a broad product portfolio for cardiac surgeons, offering solutions for the treatment of aortic, mitral and tricuspid valve disease. The MANTRA Master Plan (Master Protocol) is intended as an overarching Umbrella Protocol that allows multiple sub-studies to be added, as needed. The Umbrella Master Protocol concept offers an excellent solution to provide post-marketing clinical follow-up information on the entire cardiac surgery heart valve portfolio of the sponsor in a common database, including corelab assessment of hemodynamic and structural performance, annular motion and Dynamics for one of the products. Currently, three sub-studies are planned: * MANTRA - Aortic Sub-Study * MANTRA - Mitral/Tricuspid Sub-Study (Excluding Memo 4D) * MANTRA - Memo 4D Sub-Study

Cardiac Valve Disease

Corcym S.r.l2,150 participantsStarted Jun 2021

Indianapolis, Indiana, United States • New Orleans, Louisiana, United States • Portland, Maine, United States +49 more locations

DeepView SnapShot Portable (DV-SSP): Device Training Study

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

Find Trials by Condition in North Carolina

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

On-X Heart Valve - 17mm Aortic and 23mm Mitral

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses

Prospective SPINE Registry

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection

Epithelioid Sarcoma Natural History Study

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Control-IQ Technology in Individuals With Type 2 Diabetes

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors